| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d224bb50aa852baad7de3e53eb321af4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_26ea834074da6ca9dae059f2e48dbf87
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5bdadca494a4e73408e255d3693c64b1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-135 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-438
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4545 |
| filingDate |
2009-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d77e546de3d330d8f5394bebb78d4431
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af407ccb4c7ea922c10e24df0eea4973 |
| publicationDate |
2010-04-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010048264-A2 |
| titleOfInvention |
Methods and compositions for the treatment of immunoinflammatory disorders |
| abstract |
The invention features a method for treating a patient diagnosed with, or at risk of developing, a dermal immunoinflammatory disorder by topically administering to the patient loratadine and nortriptyline. The invention also features a topical dosage forms containing loratadine and nortriptyline. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019043064-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2549987-C1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2540764-A |
| priorityDate |
2008-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |